CLOSE

Automated glucose control at home for people with chronic disease

Description

CLOSE serves to innovate homecare for severely ill, insulin treated patients with type 2 diabetes mellitus (T2DM) by offering an integrated product and service package (AP+). Blood glucose levels will be controlled by an artificial pancreas (AP) that will be installed at the patients' home, operated through trained caregivers, and remote controlled (telehealth).The ambition of CLOSE is to improve homecare for patients, alleviate strain on supporting relatives, prevent further health complications, and reduce treatment costs.

Coordinator

Prof. Dr Freimut Schliess

Profil Institut für Stoffwechselforschung GmbH

Related News

• October 01, 2018
CLOSE: Concept Paper Acknowledges Management Support by Eurice
• February 12, 2018
Best Practice for Diabetes Patients: CLOSE Project Receives Positive Evaluation
• September 21, 2017
EURICE Expertise at EIT Health Summer School on Digital Innovation in Diabetes Care
• August 01, 2017
CLOSE Goes AP+: Creating Real Patient Value with an Artificial Pancreas
• January 10, 2017
New EIT Health KIC Innovation Project CLOSE develops and deploys an integrated package centred on closed loop metabolic control for severely ill patients with Type 2 Diabetes